ID   TRIM2_RAT               Reviewed;         744 AA.
AC   D3ZQG6;
DT   19-OCT-2011, integrated into UniProtKB/Swiss-Prot.
DT   19-OCT-2011, sequence version 2.
DT   24-JUL-2024, entry version 83.
DE   RecName: Full=Tripartite motif-containing protein 2;
DE            EC=2.3.2.27;
DE   AltName: Full=E3 ubiquitin-protein ligase TRIM2;
DE   AltName: Full=RING-type E3 ubiquitin transferase TRIM2 {ECO:0000305};
GN   Name=Trim2;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Adams M.D., Myers E.W., Smith H.O., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   FUNCTION, PROTEIN SEQUENCE OF 354-368, AND INTERACTION WITH BCL2L11.
RX   PubMed=21478148; DOI=10.1074/jbc.m110.197707;
RA   Thompson S., Pearson A.N., Ashley M.D., Jessick V., Murphy B.M., Gafken P.,
RA   Henshall D.C., Morris K.T., Simon R.P., Meller R.;
RT   "Identification of a novel Bcl-2-interacting mediator of cell death (Bim)
RT   E3 ligase, tripartite motif-containing protein 2 (TRIM2), and its role in
RT   rapid ischemic tolerance-induced neuroprotection.";
RL   J. Biol. Chem. 286:19331-19339(2011).
RN   [3]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-10; THR-371; SER-375; SER-424
RP   AND SER-428, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: UBE2D1-dependent E3 ubiquitin-protein ligase that mediates
CC       the ubiquitination of NEFL and of phosphorylated BCL2L11. Plays a
CC       neuroprotective function. May play a role in neuronal rapid ischemic
CC       tolerance. Plays a role in antiviral immunity and limits New World
CC       arenavirus infection independently of its ubiquitin ligase activity.
CC       {ECO:0000250|UniProtKB:Q9C040, ECO:0000250|UniProtKB:Q9ESN6,
CC       ECO:0000269|PubMed:21478148}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=S-ubiquitinyl-[E2 ubiquitin-conjugating enzyme]-L-cysteine +
CC         [acceptor protein]-L-lysine = [E2 ubiquitin-conjugating enzyme]-L-
CC         cysteine + N(6)-ubiquitinyl-[acceptor protein]-L-lysine.;
CC         EC=2.3.2.27;
CC   -!- PATHWAY: Protein modification; protein ubiquitination.
CC   -!- SUBUNIT: Forms homooligomers (By similarity). Interacts with TRIM3;
CC       this interaction reduces TRIM2 activity (By similarity). Interacts with
CC       myosin V; myosin V may not be a substrate for ubiquitination. Interacts
CC       with NEFL. Interacts with phosphorylated BCL2L11. Interacts with SIRPA
CC       (By similarity). {ECO:0000250|UniProtKB:Q9C040,
CC       ECO:0000250|UniProtKB:Q9ESN6}.
CC   -!- DOMAIN: The interaction with myosin V is dependent upon its NHL
CC       repeats, which form a beta-propeller (NHL) domain containing six
CC       blades. {ECO:0000250|UniProtKB:Q9ESN6}.
CC   -!- PTM: RING-type zinc finger-dependent and UBE2D1-dependent
CC       autoubiquitination. {ECO:0000250|UniProtKB:Q9ESN6}.
CC   -!- SIMILARITY: Belongs to the TRIM/RBCC family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=EDM00825.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; CH473976; EDM00825.1; ALT_SEQ; Genomic_DNA.
DR   RefSeq; NP_001102022.1; NM_001108552.1.
DR   AlphaFoldDB; D3ZQG6; -.
DR   SMR; D3ZQG6; -.
DR   BioGRID; 263094; 4.
DR   STRING; 10116.ENSRNOP00000060362; -.
DR   iPTMnet; D3ZQG6; -.
DR   PhosphoSitePlus; D3ZQG6; -.
DR   PaxDb; 10116-ENSRNOP00000060362; -.
DR   GeneID; 361970; -.
DR   KEGG; rno:361970; -.
DR   UCSC; RGD:1310981; rat.
DR   AGR; RGD:1310981; -.
DR   CTD; 23321; -.
DR   RGD; 1310981; Trim2.
DR   eggNOG; KOG2177; Eukaryota.
DR   InParanoid; D3ZQG6; -.
DR   OrthoDB; 5387006at2759; -.
DR   TreeFam; TF331018; -.
DR   UniPathway; UPA00143; -.
DR   PRO; PR:D3ZQG6; -.
DR   Proteomes; UP000002494; Unplaced.
DR   Proteomes; UP000234681; Chromosome 2.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0030371; F:translation repressor activity; IBA:GO_Central.
DR   GO; GO:0061630; F:ubiquitin protein ligase activity; ISO:RGD.
DR   GO; GO:0004842; F:ubiquitin-protein transferase activity; ISS:UniProtKB.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:1990830; P:cellular response to leukemia inhibitory factor; ISO:RGD.
DR   GO; GO:0017148; P:negative regulation of translation; IBA:GO_Central.
DR   GO; GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; IBA:GO_Central.
DR   GO; GO:0000209; P:protein polyubiquitination; IBA:GO_Central.
DR   GO; GO:0043523; P:regulation of neuron apoptotic process; IMP:UniProtKB.
DR   CDD; cd19824; Bbox2_TRIM2_C-VII; 1.
DR   CDD; cd14960; NHL_TRIM2_like; 1.
DR   CDD; cd16767; RING-HC_TRIM2; 1.
DR   Gene3D; 3.30.160.60; Classic Zinc Finger; 1.
DR   Gene3D; 2.60.40.10; Immunoglobulins; 1.
DR   Gene3D; 2.120.10.30; TolB, C-terminal domain; 2.
DR   Gene3D; 3.30.40.10; Zinc/RING finger domain, C3HC4 (zinc finger); 1.
DR   InterPro; IPR011042; 6-blade_b-propeller_TolB-like.
DR   InterPro; IPR003649; Bbox_C.
DR   InterPro; IPR017868; Filamin/ABP280_repeat-like.
DR   InterPro; IPR001298; Filamin/ABP280_rpt.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR014756; Ig_E-set.
DR   InterPro; IPR001258; NHL_repeat.
DR   InterPro; IPR050952; TRIM-NHL_E3_ligases.
DR   InterPro; IPR027370; Znf-RING_euk.
DR   InterPro; IPR000315; Znf_B-box.
DR   InterPro; IPR001841; Znf_RING.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   InterPro; IPR017907; Znf_RING_CS.
DR   PANTHER; PTHR24104; E3 UBIQUITIN-PROTEIN LIGASE NHLRC1-RELATED; 1.
DR   PANTHER; PTHR24104:SF50; TRIPARTITE MOTIF-CONTAINING PROTEIN 2; 1.
DR   Pfam; PF00630; Filamin; 1.
DR   Pfam; PF01436; NHL; 6.
DR   Pfam; PF00643; zf-B_box; 1.
DR   Pfam; PF13445; zf-RING_UBOX; 1.
DR   SMART; SM00502; BBC; 1.
DR   SMART; SM00336; BBOX; 1.
DR   SMART; SM00557; IG_FLMN; 1.
DR   SMART; SM00184; RING; 1.
DR   SUPFAM; SSF57845; B-box zinc-binding domain; 1.
DR   SUPFAM; SSF81296; E set domains; 1.
DR   SUPFAM; SSF101898; NHL repeat; 1.
DR   SUPFAM; SSF57850; RING/U-box; 1.
DR   PROSITE; PS50194; FILAMIN_REPEAT; 1.
DR   PROSITE; PS51125; NHL; 6.
DR   PROSITE; PS50119; ZF_BBOX; 1.
DR   PROSITE; PS00518; ZF_RING_1; 1.
DR   PROSITE; PS50089; ZF_RING_2; 1.
PE   1: Evidence at protein level;
KW   Direct protein sequencing; Metal-binding; Phosphoprotein;
KW   Reference proteome; Repeat; Transferase; Ubl conjugation;
KW   Ubl conjugation pathway; Zinc; Zinc-finger.
FT   CHAIN           1..744
FT                   /note="Tripartite motif-containing protein 2"
FT                   /id="PRO_0000413608"
FT   REPEAT          320..421
FT                   /note="Filamin"
FT   REPEAT          473..516
FT                   /note="NHL 1"
FT   REPEAT          520..563
FT                   /note="NHL 2"
FT   REPEAT          564..605
FT                   /note="NHL 3"
FT   REPEAT          609..652
FT                   /note="NHL 4"
FT   REPEAT          656..699
FT                   /note="NHL 5"
FT   REPEAT          700..743
FT                   /note="NHL 6"
FT   ZN_FING         23..64
FT                   /note="RING-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00175"
FT   ZN_FING         113..154
FT                   /note="B box-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00024"
FT   REGION          432..462
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         118
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00024"
FT   BINDING         121
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00024"
FT   BINDING         141
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00024"
FT   BINDING         146
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00024"
FT   MOD_RES         10
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         371
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         375
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         424
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         428
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
SQ   SEQUENCE   744 AA;  81427 MW;  83BAAB9CD325225C CRC64;
     MASEGASIPS PVVRQIDKQF LICSICLERY KNPKVLPCLH TFCERCLQNY IPAHSLTLSC
     PVCRQTSILP EKGVAALQNN FFITNLMDVL QRTPGSNGED PSILQTVTAV AAGKPLSCPN
     HDGNVMEFYC QSCETAMCRE CTEGEHAEHP TVPLKDVVEQ HKASLQVQLD AVNKRLPEID
     SALQFISEII HQLTNQKASI VDDIHSTFDE LQKTLNVRKS VLLMELEVNY GLKHKVLQSQ
     LDTLLQGQES IKSCSNFTAQ ALNHGTETEV LLVKKQMSEK LNELADQDFP LHPRENDQLD
     FIVETEGLKK SIHNLGTILT TNAVASETVA TGEGLRQTII GQPMSVTITT KDKDGELCKT
     GNAYLTAELS TPDGSVADGE ILDNKNGTYE FLYTVQKEGD FTLSLRLYDQ HIRGSPFKLK
     VIRSADVSPT TEGVKRRVKS PGSGHVKQKA VKRPASMYST GKRKENPIED DLIFRVGTKG
     RNKGEFTNLQ GVAASTSGKI LIADSNNQCV QIFSNDGQFK SRFGIRGRSP GQLQRPTGVA
     VHPSGDIIIA DYDNKWVSIF SNDGKFKTKI GSGKLMGPKG VSVDRNGHII VVDNKACCVF
     IFQPNGKIVT RFGSRGNGDR QFAGPHFAAV NSSNEIIITD FHNHSVKVFN QEGEFMLKFG
     SNGEGNGQFN APTGVAVDSN GNIIVADWGN SRIQVFDGSG SFLSYINTSA DPLYGPQGLA
     LTSDGHVVVA DSGNHCFKVY RYLQ
//
